-+ 0.00%
-+ 0.00%
-+ 0.00%

Ligand Pharmaceuticals CLO, Secretary Andrew Reardon disposes of USD 1.5 million in common shares

PUBT·10/06/2026 20:36:17
Listen to the news
Ligand Pharmaceuticals CLO, Secretary Andrew Reardon disposes of USD 1.5 million in common shares
  • Ligand Pharmaceuticals CLO and Secretary Andrew Reardon cut his common stock stake to 31,854 shares on Oct. 2, 2026.
  • Sold 5,000 shares at weighted-average prices of USD 302.5107 to USD 307.74.
  • Exercised 340 employee stock options at USD 52.27, lifting direct holdings to 36,854 shares before the sales.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ligand Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001950232-26-000003), on October 06, 2026, and is solely responsible for the information contained therein.